Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial to Evaluate the Benefit of High Dose Vitamin D3 on Aromatase Inhibitor Letrozole-Associated Musculoskeletal Symptoms and Fatigue (The VITAL Trial).

NCT00867217 is registered in ClinicalTrials.gov with Qamar Khan as lead sponsor.

NCT NCT00867217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00867217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial to Evaluate the Benefit of High Dose Vitamin D3 on Aromatase Inhibitor Letrozole-Associated Musculoskeletal Symptoms and Fatigue (The VITAL Trial).
Lead sponsor
Qamar Khan
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2009
Completion date
January 31, 2011
Enrollment
160 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer